| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |